Special Issue "Advanced Glycation End Products (AGEs) and Their Receptor RAGE"
Deadline for manuscript submissions: closed (25 October 2022) | Viewed by 12766
Interests: receptor of advanced glycation endproducts; retinoids; acute respiratory distress syndrome; premature rupture of membranes; sterile inflammation; diseases biomarkers; traumatic brain injury; S100B protein
Special Issues, Collections and Topics in MDPI journals
Several years ago, the identification and characterization of the advanced glycation end products (AGEs) gave the opportunity to link metabolic disorders (for example, hyperglycaemia) and related pathological disorders in human diseases. The recent discovery of the molecular actor of AGEs, i.e., the trans-membranous receptor of AGE (RAGE) opened up new perspectives in terms of diagnosis and therapeutic aspects of diseases related to AGEs. The complexity of RAGE binding and intracellular activation clearly proposed an interesting explanation of the plurality of the clinical manifestations of such diseases. RAGE belongs to the superfamily of patterns recognition receptors able to link several damage-associated molecular patterns called also alarmins. This molecular link places the pair “AGEs / RAGE” in the global sterile inflammation process developed in a number of acute and chronic human pathologies. This Special Issue, “Advanced Glycation End Products (AGEs) and their receptor RAGE”, aims to provide a summary of the field, to explore recent advances in the biochemical (fundamental and applied) aspects of AGEs, and to discuss what can be developed in terms of biochemistry and pharmacological tools useful for diagnosis and therapeutics in disorders linked with RAGE involvements. We invite authors to submit original research and review articles related to any of these aspects.
Prof. Dr. Vincent Sapin
Dr. Loic Blanchon
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- advanced glycation end products
- receptor of advanced glycation end products
- intracellular transduction pathways
- sterile inflammation
- damage-associated molecular patterns